Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 899 studies with search of: | United States, North Dakota |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
|
||||
2 | Active, not recruiting |
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
|
||||
3 | Recruiting |
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
|
||||
4 | Active, not recruiting |
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
|
||||
5 | Active, not recruiting |
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
|
||||
6 | Recruiting |
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
|
||||
7 | Completed |
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
|
||||
8 | Active, not recruiting |
Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
|
||||
9 | Active, not recruiting |
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
|
||||
10 | Active, not recruiting |
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
|
||||
11 | Active, not recruiting |
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
|
||||
12 | Recruiting |
Combination Chemotherapy in Treating Women With Breast Cancer
|
||||
13 | Recruiting |
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
|
||||
14 | Active, not recruiting |
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
|
||||
15 | Active, not recruiting |
AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
|
||||
16 | Active, not recruiting |
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
|
||||
17 | Recruiting |
Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
|
||||
18 | Active, not recruiting |
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
|
||||
19 | Active, not recruiting |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
|
||||
20 | Active, not recruiting |
Sorafenib in Treating Patients With Metastatic Breast Cancer
|
Previous Page | Studies Shown (1-20) | Next (21-40) |